129 related articles for article (PubMed ID: 11851003)
1. [Thiazolidinediones and PPARgamma system in repair of liver damage].
Marra F; Pastacaldi S
Recenti Prog Med; 2002 Jan; 93(1):9-15. PubMed ID: 11851003
[TBL] [Abstract][Full Text] [Related]
2. The rise and fall of troglitazone.
Bailey CJ
Diabet Med; 2000 Jun; 17(6):414-5. PubMed ID: 10975209
[No Abstract] [Full Text] [Related]
3. Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists.
Olefsky JM
J Clin Invest; 2000 Aug; 106(4):467-72. PubMed ID: 10953021
[No Abstract] [Full Text] [Related]
4. Metabolic and additional vascular effects of thiazolidinediones.
Martens FM; Visseren FL; Lemay J; de Koning EJ; Rabelink TJ
Drugs; 2002; 62(10):1463-80. PubMed ID: 12093315
[TBL] [Abstract][Full Text] [Related]
5. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
Sugiyama Y
Nihon Rinsho; 2002 Sep; 60 Suppl 9():416-21. PubMed ID: 12387027
[No Abstract] [Full Text] [Related]
6. Novel insulin sensitizers: pharmacogenomic aspects.
Otto C; Lehrke M; Göke B
Pharmacogenomics; 2002 Jan; 3(1):99-116. PubMed ID: 11966407
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor gamma (PPargamma) as a novel target for prostate cancer.
Smith MR; Kantoff PW
Invest New Drugs; 2002 May; 20(2):195-200. PubMed ID: 12099579
[TBL] [Abstract][Full Text] [Related]
8. Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Hisatake JI; Ikezoe T; Carey M; Holden S; Tomoyasu S; Koeffler HP
Cancer Res; 2000 Oct; 60(19):5494-8. PubMed ID: 11034093
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinediones -- some recent developments.
Stumvoll M
Expert Opin Investig Drugs; 2003 Jul; 12(7):1179-87. PubMed ID: 12831352
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones.
Chao L; Marcus-Samuels B; Mason MM; Moitra J; Vinson C; Arioglu E; Gavrilova O; Reitman ML
J Clin Invest; 2000 Nov; 106(10):1221-8. PubMed ID: 11086023
[TBL] [Abstract][Full Text] [Related]
11. [Pioglitazone].
Kobayashi M; Iwata M; Hiratani K
Nihon Rinsho; 2002 Sep; 60 Suppl 9():429-37. PubMed ID: 12387029
[No Abstract] [Full Text] [Related]
12. Thiazolidinediones--tools for the research of metabolic syndrome X.
Komers R; Vrána A
Physiol Res; 1998; 47(4):215-25. PubMed ID: 9803467
[TBL] [Abstract][Full Text] [Related]
13. Troglitazone: a new class of oral antihyperglycemic for the treatment of type II diabetes.
Teter ML
Nurse Pract; 1997 Jul; 22(7):119-21. PubMed ID: 9253019
[No Abstract] [Full Text] [Related]
14. Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
Sakamoto J; Kimura H; Moriyama S; Odaka H; Momose Y; Sugiyama Y; Sawada H
Biochem Biophys Res Commun; 2000 Nov; 278(3):704-11. PubMed ID: 11095972
[TBL] [Abstract][Full Text] [Related]
15. Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro.
Su JL; Winegar DA; Wisely GB; Sigel CS; Hull-Ryde EA
Hybridoma; 1999 Jun; 18(3):273-80. PubMed ID: 10475242
[TBL] [Abstract][Full Text] [Related]
16. PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?
Larsen TM; Toubro S; Astrup A
Int J Obes Relat Metab Disord; 2003 Feb; 27(2):147-61. PubMed ID: 12586994
[TBL] [Abstract][Full Text] [Related]
17. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
[TBL] [Abstract][Full Text] [Related]
18. [Thiazolidinediones--a new class of oral antidiabetic drugs].
Jermendy G; Csermely P
Orv Hetil; 2001 Jul; 142(29):1547-54. PubMed ID: 11494746
[TBL] [Abstract][Full Text] [Related]
19. [Current topics in the regulation of prostanoids--4. The feedback regulation by PPAR-gamma].
Ohara M; Sawa T
Masui; 1999 Feb; 48(2):146-51. PubMed ID: 10087822
[TBL] [Abstract][Full Text] [Related]
20. Glitazones: clinical effects and molecular mechanisms.
Stumvoll M; Häring HU
Ann Med; 2002; 34(3):217-24. PubMed ID: 12173692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
